MTNB icon

Matinas BioPharma
MTNB

Overview Fund Trends Analyst Outlook Journalist POV

39 hedge funds and large institutions have $3.66M invested in Matinas BioPharma in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

58% less capital invested

Capital invested by funds: $8.74M → $3.66M (-$5.08M)

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$204K
2
+$171K
3
+$130K
4
IA
IFP Advisors
Florida
+$130K
5
BCM
BlueCrest Capital Management
Jersey
+$107K

Top Sellers

1
-$1.04M
2
-$366K
3
-$307K
4
Northern Trust
Northern Trust
Illinois
-$219K
5
BCM
Bridgeway Capital Management
Texas
-$145K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$12K
27
$11K
28
$8K
29
$5K
30
$5K
31
$4K
32
$4K
33
$2.08K
34
$2K
35
$2K
36
$969
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3